Reporter | Business

Minnesota startups will likely see another rocky year for venture funding

Venture deals already fell about 16% in 2022. Now, investors say they will be more concerned about a company's execution and traction in the market.

How much? Latest Vikings and NFL resale-market ticket prices are here

The average resale ticket price for the game between the Vikings and Giants has moved up and down this week on SeatGeek, a secondary ticket marketplace. Tap here for a daily price update and advice about buying.

Twin Cities area bars, retailers cheer winning Vikings season

Sales of merchandise have doubled at some places, and downtown hotels and restaurants are hoping this weekend's playoff crowd amps up January.

Still looking? Ticket prices falling for Vikings-Giants playoff game

In the last few days, the average selling price for tickets to Sunday's game has notably decreased on Ticket King, a local secondary ticket provider with offices in Minneapolis and St. Paul.

Meet the Minnesota wealth managers helping elite athletes avoid financial ruin

Some athletes have lost fortunes soon after their playing days. Wealth management pros are working to protect these athletes' financial well-being.

St. Paul med-tech company MGC Diagnostics sold to Georgia company for $170M

Deal is second ownership change for the company within the last six years.

Twin Cities entrepreneurs aim to eliminate stranger danger from online resale market

Safe Resell is a cashless, e-commerce web application where payments are processed prior to the in-person exchange of goods.

Lenders have increased proportion of SBA loans to minority small business owners

SBA-backed loan programs supported over $956M for small businesses in Minnesota in fiscal year 2022.

Bus Stop Mamas job site targets parents who want to re-enter workforce

Based in the Twin Cities, the services has been used by more than 12,000 moms — and some dads — across the U.S., mostly in Minnesota, Wisconsin, North Dakota and Ohio, and also abroad.

Plymouth medical device company HistoSonics raises $100M

HistoSonics recently submitted safety and efficacy data from its liver cancer treatment clinical trials to the Food and Drug Administration and expects market authorization in 2023.